Fecal microbiota transplantation (FMT)
Fecal microbiota transplantation (FMT) is an intervention with 45 clinical trials. Currently 14 active trials ongoing. Historical success rate of 75.0%.
Success Metrics
Based on 9 completed trials
Phase Distribution
Phase Distribution
11
Early Stage
12
Mid Stage
4
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
60.0%
9 of 15 finished
40.0%
6 ended early
14
trials recruiting
45
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Multi-omics Dissection of Gut Microbiome Engraftment During FMT
Fecal Microbiota Transplantation for Primary Sclerosing Cholangitis - Randomized Study Versus Sham Transplantation
Clostridioides Difficile: Understanding Responses and Treatment Effects
Fecal Microbiota Transplantation for Steroid-Refractory Acute GI GVHD
Impact of Fecal Microbiota Transplantation in Ulcerative Colitis
Clinical Trials (45)
Multi-omics Dissection of Gut Microbiome Engraftment During FMT
Fecal Microbiota Transplantation for Primary Sclerosing Cholangitis - Randomized Study Versus Sham Transplantation
Clostridioides Difficile: Understanding Responses and Treatment Effects
Fecal Microbiota Transplantation for Steroid-Refractory Acute GI GVHD
Impact of Fecal Microbiota Transplantation in Ulcerative Colitis
A Real-World Study of Fecal Transplants for Cancer Therapy Side Effects
FMT in Triple Negative Breast Cancer Guided by ctDNA
Fecal Microbiota Transplantation to RESCUE Patients With Unresectable Hcc Progressors to First Line Therapy With AtezolizUmaB and Bevacizumab
Autologous Fecal Microbiota Transplantation (Auto-FMT) for Prophylaxis of Clostridium Difficile Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation
MTC Versus FMT in for RCDI
Stool Transplant to Control Treatment-related Diarrhea
Long-term Efficacy and Safety of Fecal Microbiota Transplantation in Patients With Ulcerative Colitis
Comparison of Three Interventions for Antibiotic-Resistant Bacteria (ARB) Decolonization From the Gastrointestinal Tract
Fecal Microbiota Transplantation in Crohn's Disease as Relay After Anti-TNF Withdrawal
Study on the Efficacy and Safety of Fecal Microbiota Transplantation in the Treatment of Steroid - Dependent /Steroid-resistant Nephrotic Syndrome in Children
FMT in Uncomplicated Diverticulitis
Safety of Stool Transplant for Patients With Difficult to Treat C. Difficile Infection
Fecal Microbiota Transplantation for Radiation Enteritis
Fecal Microbiota Transplantation in Patients With Malignancies Not Responding to Cancer Immunotherapy
Fecal Microbiota Transplantation to Relieve Symptoms of Irritable Bowel Syndrome Without Constipation
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 45